M. Ç. ÜNAL Et Al. , "NIVOLUMAB ASSOCIATED ENDOCRINE ABNORMALITIES: CHALLENGING CASES FROM A REFERENCE CLINIC," ACTA ENDOCRINOLOGICA-BUCHAREST , vol.18, no.4, pp.516-522, 2022
ÜNAL, M. Ç. Et Al. 2022. NIVOLUMAB ASSOCIATED ENDOCRINE ABNORMALITIES: CHALLENGING CASES FROM A REFERENCE CLINIC. ACTA ENDOCRINOLOGICA-BUCHAREST , vol.18, no.4 , 516-522.
ÜNAL, M. Ç., Semiz, G. G., ÖZDOĞAN, Ö., ALTAY, C., YILDIRIM, E., SEMİZ, H. S., ... ÇÖMLEKÇİ, A.(2022). NIVOLUMAB ASSOCIATED ENDOCRINE ABNORMALITIES: CHALLENGING CASES FROM A REFERENCE CLINIC. ACTA ENDOCRINOLOGICA-BUCHAREST , vol.18, no.4, 516-522.
ÜNAL, MEHMET Et Al. "NIVOLUMAB ASSOCIATED ENDOCRINE ABNORMALITIES: CHALLENGING CASES FROM A REFERENCE CLINIC," ACTA ENDOCRINOLOGICA-BUCHAREST , vol.18, no.4, 516-522, 2022
ÜNAL, MEHMET Ç. Et Al. "NIVOLUMAB ASSOCIATED ENDOCRINE ABNORMALITIES: CHALLENGING CASES FROM A REFERENCE CLINIC." ACTA ENDOCRINOLOGICA-BUCHAREST , vol.18, no.4, pp.516-522, 2022
ÜNAL, M. Ç. Et Al. (2022) . "NIVOLUMAB ASSOCIATED ENDOCRINE ABNORMALITIES: CHALLENGING CASES FROM A REFERENCE CLINIC." ACTA ENDOCRINOLOGICA-BUCHAREST , vol.18, no.4, pp.516-522.
@article{article, author={MEHMET ÇAĞRI ÜNAL Et Al. }, title={NIVOLUMAB ASSOCIATED ENDOCRINE ABNORMALITIES: CHALLENGING CASES FROM A REFERENCE CLINIC}, journal={ACTA ENDOCRINOLOGICA-BUCHAREST}, year=2022, pages={516-522} }